Asymmetric Hydrogenative Coupling of Indoles with Unsaturated Ketones Enabled by Copper/Ruthenium Relay Catalysis
Synthesis · 15.11.2024 · 56 (22) · 3390-3398
DOI: 10.1055/a-2295-5417 ↗Kurz gefasst
Fachartikel in der Zeitschrift Synthesis, erschienen am 15.11.2024. Verfasst von Jian Zhang und 6 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, Shaanxi Normal University.
Abstract (Originalsprache)
A relay catalytic system is developed for the asymmetric hydrogenative coupling of indoles with α,β-unsaturated ketones, affording enantioenriched chiral γ-indole alcohols with broad substrate scope and excellent enantioselectivities (32 examples, up to >99% ee). Mechanistic studies suggest that the relay catalytic system consists of copper-catalyzed alkylation and ruthenium-catalyzed asymmetric hydrogenation.
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
- Shaanxi Normal University
- Natural Science Basic Research Program of Shaanxi Province
- 111 project
Zitieren
APA
Zhang, J., Guo, C., Wang, C., Tang, W., Xue, D., Sun, H., & Xiao, J. (2024). Asymmetric Hydrogenative Coupling of Indoles with Unsaturated Ketones Enabled by Copper/Ruthenium Relay Catalysis. Synthesis, 56(22), 3390-3398. https://doi.org/10.1055/a-2295-5417
Vancouver
Zhang J, Guo C, Wang C, Tang W, Xue D, Sun H, et al. Asymmetric Hydrogenative Coupling of Indoles with Unsaturated Ketones Enabled by Copper/Ruthenium Relay Catalysis. Synthesis. 2024;56(22):3390-3398. doi:10.1055/a-2295-5417
BibTeX
@article{Zhang2024,
author = {Zhang, Jian and Guo, Chen and Wang, Chao and Tang, Weijun and Xue, Dong and Sun, Huaming and Xiao, Jianliang},
title = {Asymmetric Hydrogenative Coupling of Indoles with Unsaturated Ketones Enabled by Copper/Ruthenium Relay Catalysis},
journal = {Synthesis},
year = {2024},
volume = {56},
number = {22},
pages = {3390--3398},
doi = {10.1055/a-2295-5417}
}
EUVIMED